{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:20:12Z","timestamp":1791062412065,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/ftd.0b013e3181dbd712","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T02:30:19Z","timestamp":1274149819000},"page":"433-437","source":"Crossref","is-referenced-by-count":30,"title":["Monitoring of Azathioprine Metabolites in Pediatric Patients With Autoimmune Hepatitis"],"prefix":"10.1097","volume":"32","author":[{"given":"Thi-Mai-Hoang","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Daubard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Le Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Larger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lachaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselyne","family":"Boulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2006.05.011","article-title":"Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of patients with autoimmune hepatitis.","volume":"45","author":"Heneghan","year":"2006","journal-title":"J Hepatol"},{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7861\/clinmedicine.6-1-25","article-title":"Autoimmune hepatitis.","volume":"6","author":"Lueth","year":"2006","journal-title":"Clin Med"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mam.2007.09.009","article-title":"Autoimmune liver disease 2007.","volume":"29","author":"Muratori","year":"2008","journal-title":"Mol Aspects Med"},{"key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00005176-200209000-00032","article-title":"Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report.","volume":"35","author":"Rumbo","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/jhep.2002.30991","article-title":"Current and novel immunosuppressive therapy for autoimmune hepatitis.","volume":"35","author":"Heneghan","year":"2002","journal-title":"Hepatology"},{"key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","article-title":"The clinical pharmacology of 6-mercaptopurine.","volume":"43","author":"Lennard","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10637-005-4020-8","article-title":"The thiopurine: an update.","volume":"23","author":"Coulthard","year":"2005","journal-title":"Invest New Drugs"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00003088-200746030-00001","article-title":"Thiopurine treatment in inflammatory bowel disease.","volume":"46","author":"Telm","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1053\/j.gastro.2006.01.048","article-title":"American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.","volume":"130","author":"Lichtenstein","year":"2006","journal-title":"Gastroenterology"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2006.02980.x","article-title":"Thiopurines in inflammatory bowel disease.","volume":"24","author":"Derijks","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1440-1746.2005.03832.x","article-title":"Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.","volume":"20","author":"Gearry","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1399-3046.2004.00230.x","article-title":", Schneider B, Emre S. Utility of azathioprine metabolite measurement in post-transplant recurrent autoimmune and autoimmune-mediated hepatitis.","volume":"8","author":"Rumbo","year":"2004","journal-title":"Pediatr Tranplant"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/00042737-200412000-00028","article-title":"Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis.","volume":"16","author":"Wusk","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/clinchem\/44.12.2511","article-title":"Identification of 6-methylmercaptopurine derivative formed during acid hydrolysis of thiopurine nucleotides in erythrocytes, using liquid chromatography-mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance assay.","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin Chem"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/44.3.551","article-title":"Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC.","volume":"44","author":"Dervieux","year":"1998","journal-title":"Clin Chem"},{"key":"R16-8-20210129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/clinchem\/47.5.956","article-title":"Phenotype determination of thiopurine methyltransferase in erythrocytes by HPLC.","volume":"47","author":"Boulieu","year":"2001","journal-title":"Clin Chem"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/gut.39.3.401","article-title":"6-Mercaptopurine metabolism in Crohns disease: correlation with efficacy and toxicity.","volume":"39","author":"Cuffari","year":"1996","journal-title":"Gut"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1046\/j.1365-2036.2000.00812.x","article-title":"Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy.","volume":"14","author":"Cuffari","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-8-20210129","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gut.49.5.665","article-title":"Measurement of thiopurine methyl transferase activity and azathoprine metabolites in patients with inflammatory bowel disease.","volume":"49","author":"Lowry","year":"2001","journal-title":"Gut"},{"key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/gut.34.8.1081","article-title":"Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.","volume":"34","author":"Connell","year":"1993","journal-title":"Gut"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e3181dbd712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:21:52Z","timestamp":1786040512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-201008000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3181dbd712","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}